Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick #8 Kura Oncology; Positive Ziftomenib And 7+3 1st-Line AML Data, PDUFA Date November 30th 2025 Ziftomenib Established And ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #8 is a biotech by the name of Kura Oncology (KURA). The reason why I want to go over this biotech again ...
Seeking Alpha

Biotech Analysis Central Model 10+ Portfolio Pick#18 Annovis Bio; 6-Month Path Forward Possible For Buntanetap In AD, Q1 2025 Phase 3 Study Initiation And Catalysts

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #18 is a biotech by the name of Annovis Bio (ANVS)The reason why I wanted to go over this biotech next as ...
Nasdaq

Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...
Morning Overview on MSN

Mantis Biotech builds human digital twins to tackle medical data gaps

Mantis Biotechnology Corp, a San Francisco-based startup, is building simulated human bodies to generate the synthetic ...
Morningstar

Atelerix Enters Agreement with Cherry Biotech to Integrate Non-cryogenic Transport Solutions With Advanced Organoid Models

Partnership brings together proven non-cryogenic biosample preservation technology and advanced organoid models to support growth in preclinical research and biotech sectors Atelerix, a biotech ...
News Medical

Atelerix enters agreement with Cherry Biotech to integrate non-cryogenic transport solutions with advanced organoid models

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered a partnership with Cherry ...